Neuroblastoma - PubMed (original) (raw)
Review
Neuroblastoma
Nadja C Colon et al. Adv Pediatr. 2011.
No abstract available
Figures
Figure 1
International Neuroblastoma Risk Group (INRG) Classification. L1, localized tumor confined to one body compartment and with absence of image-defined risk factors (IDRFs); L2, locoregional tumor with presence of one or more IDRFs; M, distant metastatic disease (except stage MS); MS, metastatic disease confined to skin, liver and/or bone marrow in children < 18 months of age; EFS, event-free survival (From Cohn et al, The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report.J Clin Onc; 2009; Fig. 2, p.295; with permission).
Figure 2
Effects of GRP-receptor knockdown on neuroblastoma metastasis in vivo. Spleen injection liver metastasis murine model was used using human neuroblastoma BE(2)-C cells transfected with pEGFP/shGRP-R (silenced GRP receptors) or pEGFP/shCON (controls). (A) Representative images of livers from mice injected with BE(2)-C/GFP/shGRP-R (short-hairpin silenced GRP-receptors) and control cells (shCON). Silencing of GRP-receptors (shGRP-R; right column) attenuated liver metastasis of BE(2)-C tumors. Quantitative analysis of liver weight relative to body weight (* p<0.05 vs. shCON) shows significantly less weight in GRP-R silenced group (B) Representative H&E-stained sections of livers from mice injected with BE(2)-C/GFP/shCON (controls; upper) and BE(2)-C/GFP/shGRP-R (GRP receptor silenced; lower) cells. Extensive liver metastases are seen in mice from constitutive GRP-receptor expressing BE(2)-C cells (upper). (Adapted from Qiao et al, Proc Natl Acad Sci 2008; Fig. 6, p.12895. Copyright2008 National Academy of Sciences, U.S.A).
Similar articles
- Neuroblastoma in childhood: review and radiological findings.
Papaioannou G, McHugh K. Papaioannou G, et al. Cancer Imaging. 2005 Sep 30;5(1):116-27. doi: 10.1102/1470-7330.2005.0104. Cancer Imaging. 2005. PMID: 16305949 Free PMC article. Review. - Neuroblastoma imaging.
Ley S, Ley-Zaporozhan J, Günther P, Deubzer HE, Witt O, Schenk JP. Ley S, et al. Rofo. 2011 Mar;183(3):217-25. doi: 10.1055/s-0029-1245903. Epub 2010 Dec 17. Rofo. 2011. PMID: 21170823 Review. - [Current strategy for the imaging of neuroblastoma].
Brisse H, Edeline V, Michon J, Couanet D, Zucker J, Neuenschwander S. Brisse H, et al. J Radiol. 2001 Apr;82(4):447-54. J Radiol. 2001. PMID: 11353899 Review. French. - [Neuroblastoma. Results of protocol N-I-87].
Castel Sánchez V, Badal Iranzo MD, Bezanilla Regato JL, Herrero Díez A, Llombart Bosch A, Ruiz Jiménez JI, Sánchez de Toledo J. Castel Sánchez V, et al. An Esp Pediatr. 1993 May;38(5):471-6. An Esp Pediatr. 1993. PMID: 8503598 Spanish. No abstract available. - Neuroblastoma: contemporary management.
Mullassery D, Dominici C, Jesudason EC, McDowell HP, Losty PD. Mullassery D, et al. Arch Dis Child Educ Pract Ed. 2009 Dec;94(6):177-85. doi: 10.1136/adc.2008.143909. Arch Dis Child Educ Pract Ed. 2009. PMID: 19933390 Review. No abstract available.
Cited by
- Severe labile hypertension in a patient with catecholamine-secreting neuroblastoma: a case report.
Frisby-Zedan J, Migotsky M, Walterhouse DO, Verghese PS. Frisby-Zedan J, et al. Pediatr Nephrol. 2024 Jul;39(7):2087-2090. doi: 10.1007/s00467-023-06269-2. Epub 2024 Jan 23. Pediatr Nephrol. 2024. PMID: 38261065 - The Dramatic Consequences of an Accidental Ligation of the Celiac Trunk during Surgery Performed on a Child with Neuroblastoma.
Sosnowska-Sienkiewicz P, Januszkiewicz-Lewandowska D, Mańkowski P. Sosnowska-Sienkiewicz P, et al. Int J Environ Res Public Health. 2021 Feb 14;18(4):1841. doi: 10.3390/ijerph18041841. Int J Environ Res Public Health. 2021. PMID: 33672809 Free PMC article. - Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies.
Peleli M, Moustakas A, Papapetropoulos A. Peleli M, et al. Int J Mol Sci. 2020 Oct 6;21(19):7371. doi: 10.3390/ijms21197371. Int J Mol Sci. 2020. PMID: 33036204 Free PMC article. Review. - Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy.
Valind A, Verhoeven BM, Enoksson J, Karlsson J, Christensson G, Mañas A, Aaltonen K, Jansson C, Bexell D, Baryawno N, Gisselsson D, Hagerling C. Valind A, et al. Oncoimmunology. 2023 Mar 1;12(1):2184130. doi: 10.1080/2162402X.2023.2184130. eCollection 2023. Oncoimmunology. 2023. PMID: 36875552 Free PMC article. - The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo.
Flynn SM, Lesperance J, Macias A, Phanhthilath N, Paul MR, Kim JW, Tamayo P, Zage PE. Flynn SM, et al. Oncotarget. 2019 Oct 29;10(59):6323-6333. doi: 10.18632/oncotarget.27259. eCollection 2019 Oct 29. Oncotarget. 2019. PMID: 31695841 Free PMC article.
References
- Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010;24:65–86. - PubMed
- Esiashvili N, Anderson C, Katzenstein HM. Neuroblastoma. Curr Probl Cancer. 2009;33:333–360. - PubMed
- Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203–216. - PubMed
- London WB, Matthay KK, Ambros PF, et al. Clinical and biological features predictive of survival after relapse of neuroblastoma: A study from the International Neuroblastoma (NB) Risk Group (INRG) Database. J Clin Oncol. 2010;28:9518.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical